Evolus Inc buy stratec
Start price
20.05.19
/
50%
€14.97
Target price
24.10.20
€8.00
Performance (%)
-81.26%
End price
24.10.20
€2.81
Summary
This prediction ended on 24.10.20 with a price of €2.81. The BUY prediction by stratec for Evolus Inc performed very badly with a performance of -81.26%. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Evolus Inc | -2.679% | -2.679% | 39.744% | 37.107% |
| iShares Core DAX® | 0.160% | -1.640% | 12.016% | 15.557% |
| iShares Nasdaq 100 | -3.020% | -4.715% | 37.102% | 42.685% |
| iShares Nikkei 225® | -2.519% | -7.621% | 18.066% | 2.904% |
| iShares S&P 500 | -1.377% | -2.809% | 26.536% | 41.689% |
Comments by stratec for this prediction
In the thread Evolus Inc diskutieren
stratec stimmt der Buy-Einschätzung von klostergang zu
stratec stimmt am 20.05.2019 der Buy-Einschätzung von klostergang mit dem Kursziel 35$ zu.
Überschrift: Evolus obtained FDA approval for its product Jeuveau to treat patients with glabellar lines.
Es gibt keinen Handelsplatz
Kursziel geändert auf 8,0